HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phosphorylation of androgen receptor by mTORC1 promotes liver steatosis and tumorigenesis.

AbstractBACKGROUND AND AIMS:
Androgen receptor (AR) has been reported to play an important role in the development and progression of man's prostate cancer. Hepatocellular carcinoma (HCC) is also male-dominant, but the role of AR in HCC remains poorly understood. Mechanistic target of rapamycin complex 1 (mTORC1) also has been reported to be highly activated in HCC. In this study, we aimed to explore the role of AR phosphorylation and its relationship with mTORC1 in hepatocarcinogenesis.
APPROACH AND RESULTS:
In vitro experiment, we observed that mTORC1 interacts with hepatic AR and phosphorylates it at S96 in response to nutrient and mitogenic stimuli in HCC cells. S96 phosphorylation promotes the stability, nuclear localization, and transcriptional activity of AR, which enhances de novo lipogenesis and proliferation in hepatocytes and induces liver steatosis and hepatocarcinogenesis in mice independently and cooperatively with androgen. Furthermore, high ARS96 phosphorylation is observed in human liver steatotic and HCC tissues and is associated with overall survival and disease-free survival, which has been proven as an independent survival predictor for patients with HCC.
CONCLUSIONS:
AR S96 phosphorylation by mTORC1 drives liver steatosis and HCC development and progression independently and cooperatively with androgen, which not only explains why HCC is man-biased but also provides a target molecule for prevention and treatment of HCC and a potential survival predictor in patients with HCC.
AuthorsQian-Nan Ren, Hong Zhang, Chao-Yue Sun, Yu-Feng Zhou, Xue-Feng Yang, Jian-Wu Long, Xiao-Xing Li, Shi-Juan Mai, Mei-Yin Zhang, Hui-Zhong Zhang, Hai-Qiang Mai, Min-Shan Chen, X F Steven Zheng, Hui-Yun Wang
JournalHepatology (Baltimore, Md.) (Hepatology) Vol. 75 Issue 5 Pg. 1123-1138 (05 2022) ISSN: 1527-3350 [Electronic] United States
PMID34435708 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2021 The Authors. Hepatology published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases.
Chemical References
  • Androgens
  • Receptors, Androgen
  • Mechanistic Target of Rapamycin Complex 1
Topics
  • Androgens
  • Animals
  • Carcinogenesis
  • Carcinoma, Hepatocellular (pathology)
  • Cell Transformation, Neoplastic
  • Fatty Liver
  • Humans
  • Liver Neoplasms (pathology)
  • Male
  • Mechanistic Target of Rapamycin Complex 1 (metabolism)
  • Mice
  • Phosphorylation
  • Receptors, Androgen (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: